Liabilities and Equity of Core Laboratories Inc. /DE/ from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Core Laboratories Inc. /DE/ quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Core Laboratories Inc. /DE/ Liabilities and Equity for the quarter ending 30 Sep 2025 was $591,360,000, a 1.5% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Core Laboratories Inc. /DE/ Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $591,360,000 -$9,106,000 -1.5% 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 $602,111,000 +$4,312,000 +0.72% 30 Jun 2025 10-Q 25 Jul 2025 2025 Q2
Q1 2025 $591,519,000 +$3,569,000 +0.61% 31 Mar 2025 10-Q 28 Apr 2025 2025 Q1
Q4 2024 $590,406,000 +$4,011,000 +0.68% 31 Dec 2024 10-Q 23 Oct 2025 2025 Q3
Q3 2024 $600,466,000 +$8,052,000 +1.4% 30 Sep 2024 10-Q 24 Oct 2024 2024 Q3
Q2 2024 $597,799,000 -$4,049,000 -0.67% 30 Jun 2024 10-Q 25 Jul 2024 2024 Q2
Q1 2024 $587,950,000 31 Mar 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 $586,395,000 +$8,041,000 +1.4% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $592,414,000 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $601,848,000 30 Jun 2023 10-Q 27 Jul 2023 2023 Q2
Q4 2022 $578,354,000 31 Dec 2022 10-K 15 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.